Tag Archives: PTC

05Jun/18
Quality+IoMT-800x600

New Research: The Impact of the Internet of Medical Things (IoMT) on Patient Outcomes

Axendia conducted a research study focusing on the medical device industry’s ability to build a Culture of Innovation and Quality and we sought to understand the Impact of the Internet of Medical Things (IoMT) on Patient Outcomes and how IoMT is changing the business of healthcare.

We successfully identified and analyzed trends, requirements and initiatives organizations are undertaking to proactively manage products and platforms across the product lifecycle.
In addition to our latest e-Book, we also developed an Infographic.

 

Request your copy now and learn:

  • How the medical device business will change over the next five years as a result of IoT initiatives
  • The biggest challenges companies face when bringing smart, connected devices to market
  • The biggest patient benefits of smart, connected devices
  • What type of medical device companies see IoMT as the biggest business disruptor

In support of the research, we surveyed 110 medical device professionals representing 59 medical device manufacturers from 12 countries, and engaged in one-on-one interviews and group discussions with industry thought leaders.

05Apr/18
Axendia_Sysmex Final April 2018-secured_Page_01

Case Study: SYSMEX Leverages the Internet of Medical Things (IoMT) to Disrupt the Blood Testing Market

Sysmex Aims to Improve Health Care for Millions of Patients by Going Beyond “Building a Better Box” and Leveraging the Power of IoMT

By: Daniel R. Matlis, President and Sandra K. Rodriguez, Market Analyst

Axendia_Sysmex-HighlightToday, the goal of healthcare is improving diagnostics and patient outcomes. To this end, the healthcare ecosystem is undergoing a transformation aimed at improving the quality of care while simultaneously controlling costs. In simple terms, the model is shifting from sick-care to well-care.

The power of the Internet of Medical Things (IoMT) and advanced technologies are enabling businesses to think outside the box.  In the case of Sysmex, the company went beyond just ‘building a better box’ in support of improved patient outcomes.

Learn how the company is disrupting the blood testing market in our latest IoMT Case Study, as we highlight:

  • How Sysmex Disrupted the Blood Testing Market via IoMT powered by PTC’s ThingWorx Platform
  • How IoMT Created a Digital Safety Shields in Support of Patient Safety
  • What are the Four Corner Stones of ‘Going Beyond Building a Better Box’
  • How the Combination of IoMT and AR are Bringing Disruption to the Next Level
  • How Next Generation Connected-Product Improve Patient Outcomes

To receive your copy of the Case Study, please register here.

04Apr/18
Quality+IoMT-800x600

Quality: STOP Working on Compliance

Excessive focus on compliance can create hurdles in cultivating quality and innovation

By: Daniel R. Matlis, President

What is the role of Quality in MedTech? 10% said the primary role of quality is to drive product / process improvement. In sharp contrast, 85% indicated the primary role of quality is ensuring compliance

No wonder, the industry has to overcome some many hurdles when cultivating a culture of quality and innovation.

To compete in today’s global markets, Med-Tech companies must change their approach to Quality, from meeting compliance requirements, to driving product and process improvements across the product life-cycle.

A closed loop approach can help MedTech organizations make this crucial shift by enabling better collaboration, visibility and product quality across the product life-cycle.

Axendia_CultureQuality

Read my latest Soapbox column in MedTech Intelligence for key takeaways from Axendia’s research on this topic.

22Feb/18
Infographics Top Section Square - 2 - 240 by 181

New Research: Driving a Culture of Quality Within the Medical Device Ecosystem

Axendia conducted a study focusing on the medical device induCulture of Quality Infographicstry’s ability to build a “Culture of Innovation and Quality.” The goals of this research were to identify and analyze trends, requirements and initiatives organizations are undertaking to proactively manage products and platforms across the product lifecycle.

In support of the research, we surveyed 110 medical device professionals representing 59 medical device manufacturers from 12 countries, and engaged in one-on-one interviews and group discussions with industry thought leaders.

The research resulted in an e-Book: Driving a Culture of Quality Within the Medical Device Manufacturing Ecosystem.  In it, we discuss the value, challenges and opportunities of transitioning medical device companies from the current regulatory and compliance focus – to sustained, predictive practices that advance medical device quality and safety to achieve better patient outcomes.  We also reveal how the Industry is prioritizing investments in technology in support of quality initiatives.

See the Infographic to learn more.

Read the e-Book.

05Apr/17
Europe Conf

CLOSED LOOP PRODUCT LIFECYCLE MANAGEMENT

By: Eric M. Luyer, Market Research Analyst and Daniel R. Matlis, President

What Does it Mean to Medical Device Manufacturers?

Digital Transformation was the key topic at the PTC European Forum, held November 15th in Stuttgart, Germany.  Part of the day was devoted to clarifying how the Internet of Things (IoT) and Augmented Reality (AR), in relation to digital transformation, benefit decision-making processes.

We are living in a time where it seems like everyone and everything is getting connected using technology concepts such as IoT.  At the same time, there is a strong focus on improving product quality and value.  However, the products or related services are getting more complex and the market requires product delivery be on request.

PTC Europe ImageIt is interesting to hear and learn how new concepts and technologies such as IoT and augmented reality (AR) can be used specifically in the medical device industry: to drive success with the ability to create, produce and market innovative and value driven products to market quickly.

Certainly, in a global market, proactive strategies are needed to support improved product quality and patient outcomes while supporting compliance with applicable regulatory requirements.

Continue reading